All In MedTech

Device Trial Radar · NCT07358351

Feasibility of Robotic Instrument Guidance System to Perform Safe Ultrasound-Guided Percutaneous Procedures During Routine Medical Procedures.

Feasibility of Robotic Instrument Guidance System to Perform Safe Ultrasound-Guided Percutaneous Procedures

Last checked: Nov 20, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

46

Actual

Start

Dec 3, 2025

Primary completion

Dec 12, 2025

Study completion Feb 2026

Sponsor

Lead sponsor
Mendaera, IncNot on our public-company list
Sponsor type
Industry
Collaborators
CBCC Global Research LLP
First posted
Jan 22, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Mendaera Guidance System ("Study Device") is intended to provide guidance for precise instrument placement of common percutaneous devices by positioning the device relative to the ultrasound transducer and the resulting image during a diagnostic or therapeutic procedure. After instrument placement is achieved, investigator will perform any further clinical tasks, procedures, or treatment using standard of care. The target population for whom this device is intended includes participants requiring ultrasound guided, percutaneous procedures. Participants who are scheduled to undergo an ultrasound-guided procedure will be consented and enrolled in the study. Prior to the study procedure, participants should be prepared for ultrasound-guided procedure using standard of care. Once the investigator determines that an ultrasound-guided procedure can be performed, the compatible percutaneous instrument will be connected to the Study Device, and the investigator may proceed to utilize the System to perform targeting and depth tracking of the instrument. Once access has been achieved, Participation will conclude after the first follow-up which is anticipated to be within 24±12 hours.

Conditions

  • Percutaneous Access

Interventions

  • Mendaera Guidance SystemDevice

    Precise instrument placement of common percutaneous access devices for participants undergoing an ultrasound-guided procedure. Placement is conducted during routine care where percutaneous access is required.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Device-Related Adverse Events (occurrence and severity)Time frame: From enrollment to 24 hour follow-up (+/- 12 hours)

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mendaera, Inc

    San Mateo, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.